Preferential activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu
H
H
Tagami
H
H
D051561:Complement C3 Convertase, Alternative Pathway; D003179:Complement C3b / Q000032:analysis*; D003181:Complement C4 / Q000032:analysis*; D015935:Complement C4b; D003170:Complement Pathway, Alternative / Q000502:physiology*; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis*; D011565:Psoriasis / Q000276:immunology*; D012867:Skin / Q000276:immunology
D003181:Complement C4; D010446:Peptide Fragments; D003179:Complement C3b; D015935:Complement C4b; C032261:complement C4d; D051561:Complement C3 Convertase, Alternative Pathway